Common Contracts
5 similar Retention Agreement contracts by Obalon Therapeutics Inc
RETENTION AGREEMENTRetention Agreement • May 10th, 2018 • Obalon Therapeutics Inc • Surgical & medical instruments & apparatus • California
This Retention Agreement (the “Agreement”) is entered into by and between [_____________] (the “Executive”) and Obalon Therapeutics, Inc., a Delaware corporation (the “Company”), on [__________], and is effective on the date on which the Executive commences employment with the Company (the “Effective Date”).
Retention AgreementRetention Agreement • November 10th, 2016 • Obalon Therapeutics Inc • Surgical & medical instruments & apparatus • California
This Retention Agreement (the “Agreement”) is entered into by and between [Name] (the “Executive”) and Obalon Therapeutics, Inc., a Delaware corporation (the “Company”), on _________ __, 2016, and is effective on the first date on which a registration statement covering the initial public offering of the common stock of the Company is declared effective by the United States Securities and Exchange Commission (the “Effective Date”).
Retention AgreementRetention Agreement • November 10th, 2016 • Obalon Therapeutics Inc • Surgical & medical instruments & apparatus • California
This Retention Agreement (the “Agreement”) is entered into by and between Andrew Rasdal (the “Executive”) and Obalon Therapeutics, Inc., a Delaware corporation (the “Company”), on October 10, 2016, and is effective on the first date on which a registration statement covering the initial public offering of the common stock of the Company is declared effective by the United States Securities and Exchange Commission (the “Effective Date”).
RETENTION AGREEMENTRetention Agreement • September 26th, 2016 • Obalon Therapeutics Inc • Surgical & medical instruments & apparatus • California
This Retention Agreement (the “Agreement”) is entered into by and between [Name] (the “Executive”) and Obalon Therapeutics, Inc., a Delaware corporation (the “Company”), on , 2016, and is effective on the first date on which a registration statement covering the initial public offering of the common stock of the Company is declared effective by the United States Securities and Exchange Commission (the “Effective Date”).
RETENTION AGREEMENTRetention Agreement • September 26th, 2016 • Obalon Therapeutics Inc • Surgical & medical instruments & apparatus • California
This Retention Agreement (the “Agreement”) is entered into by and between [Name] (the “Executive”) and Obalon Therapeutics, Inc., a Delaware corporation (the “Company”), on , 2016, and is effective on the first date on which a registration statement covering the initial public offering of the common stock of the Company is declared effective by the United States Securities and Exchange Commission (the “Effective Date”).
